Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial)

Phillip H. Kuo, Michael J. Morris, Jacob Hesterman, A. Tuba Kendi, Kambiz Rahbar, Xiao X. Wei, Bruno Fang, Nabil Adra, Rohan Garje, Jeff M. Michalski, Kim Chi, Johann de Bono, Karim Fizazi, Bernd Krause, Oliver Sartor, Scott T. Tagawa, Samson Ghebremariam, Marcia Brackman, Connie C. Wong, Ana M. CatafauTaylor Benson, Andrew J. Armstrong, Ken Herrmann

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Keyphrases